Puzio-Kuter A M, Laddha S V, Castillo-Martin M, Sun Y, Cordon-Cardo C, Chan C S, Levine A J
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Icahn School of Medicine at Mount Sinai, Mount Sinai School of Medicine, New York, USA.
Cell Death Differ. 2015 Nov;22(11):1785-91. doi: 10.1038/cdd.2015.27. Epub 2015 Mar 27.
Liposarcoma (LPS) is a type of soft tissue sarcoma that mostly occurs in adults, and in humans is characterized by amplifications of MDM2 and CDK4. The molecular pathogenesis of this malignancy is still poorly understood and, therefore, we developed a mouse model with conditional inactivation of PTEN and p53 to investigate these pathways in the progression of the disease. We show that deletion of these two tumor suppressors cooperate in the formation of multiple subtypes of LPS (from well-differentiated LPS to pleomorphic LPS). In addition, progression of the tumors is further characterized by the expression of D cyclins and CDK4/6, which allow for continued cell division. Microarray analysis also revealed novel genes that are differentially expressed between different subtypes of LPS, which could aid in understanding the disease and to unravel potential new therapeutic targets.
脂肪肉瘤(LPS)是一种软组织肉瘤,主要发生于成年人,在人类中其特征为MDM2和CDK4的扩增。这种恶性肿瘤的分子发病机制仍知之甚少,因此,我们构建了一种条件性失活PTEN和p53的小鼠模型,以研究这些通路在疾病进展中的作用。我们发现,这两种肿瘤抑制因子的缺失共同作用于多种脂肪肉瘤亚型(从高分化脂肪肉瘤到多形性脂肪肉瘤)的形成。此外,肿瘤进展的进一步特征是D型细胞周期蛋白和CDK4/6的表达,它们使得细胞能够持续分裂。微阵列分析还揭示了在不同脂肪肉瘤亚型之间差异表达的新基因,这有助于理解该疾病并揭示潜在的新治疗靶点。